F293-0756 Screening compound: 5-(4-cyclohexylbenzenesulfonamido)-2-(morpholin-4-yl)pyridine-3-carboxylic acid

F293-0756 Screening compound: 5-(4-cyclohexylbenzenesulfonamido)-2-(morpholin-4-yl)pyridine-3-carboxylic acid
F293-0756 Screening compound: 5-(4-cyclohexylbenzenesulfonamido)-2-(morpholin-4-yl)pyridine-3-carboxylic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound F293-0756
5-(4-cyclohexylbenzenesulfonamido)-2-(morpholin-4-yl)pyridine-3-carboxylic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F293-0756

Molecular Formula

C22H27N3O5S (C22 H27 N3 O5 S)

Compound Name

5-(4-cyclohexylbenzenesulfonamido)-2-(morpholin-4-yl)pyridine-3-carboxylic acid

IUPAC name

5-(4-cyclohexylbenzenesulfonamido)-2-(morpholin-4-yl)pyridine-3-carboxylic acid

SMILES

OC(c1cc(NS(c2ccc(C3CCCCC3)cc2)(=O)=O)cnc1N1CCOCC1)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

CF3COOH

Molecular Weight

445.54

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.608

Distribution Coefficient, logD

3.001

Water Solubility, LogSw

-4.08

Polar Surface Area

89.648

Acid Dissociation Constant (pKa)

5.80

Base Dissociation Constant (pKb)

2.88

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

45.50

F293-0756 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

SH2 Library (10483 compounds)

Akt-Targeted Library (14764 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Endocrine
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Kinases
  • Kinases
  • Phosphatases
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with F293-0756 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F293-0756?
Check Price and Availability of F293-0756, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F293-0756 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F293-0756
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F293-0756
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F293-0756 available by request